Newsroom

Commencement Of Work On The Australian Bragg Centre

ProTom International welcomes the South Australian Government’s announcement of the commencement of work on the Australian Bragg Centre.

Wakefield, Mass., June 10, 2020 - ProTom International is pleased to announce that it will install its Radiance 330® Proton Therapy System at the new Australian Bragg Centre, Adelaide, Australia. This center will be the first clinically dedicated proton therapy center in Australia and the Southern Hemisphere, expecting to start operation in 2024. 

This installation will include two gantries, one fixed beam line and a research port. The Bragg Centre will operate as a clinic as well as a research facility.

The Australian Bragg Centre is a purpose-built facility to be established within the South Australian Health and Medical Research Institute (“SAHMRI”) in Adelaide, South Australia. Work has commenced on the center, to be located within a new 15 story building (“SAHMRI 2”) in the $3.6 billion Adelaide Bio Med City - alongside the new Royal Adelaide Hospital, SAHMRI’s existing building, the University of Adelaide Health and Medical Sciences Building, and the University of South Australia’s Health Innovation Building.

The new proton therapy center in Adelaide will allow Australia’s radiation oncologists to refer patients for targeted cancer tumor treatment with minimal damage to surrounding healthy tissue. This makes it a particularly preferable treatment option for children. In addition, the system will be used by SAHMRI researchers as they continue to develop new ways to diagnose and treat cancer. This new center will make proton therapy treatment available to many more Australians, without the need to travel to other countries.

About ProTom

ProTom International is a leading device manufacturer of proton therapy technology. We are steadfast in our mission to transform cancer treatment by expanding the accessibility of proton therapy and by developing proton tomography technology.

Combined with the fast return on investment and the precision of pencil beam scanning and the power of integrated imaging, ProTom’s Radiance 330® proton therapy system is the choice for future proton therapy technology.

For more information, please visit: https://www.protominternational.com

About SAHMRI

SAHMRI was the first laboratory building in Australia to be certified as a Leadership in Energy and Environment Design (LEED) Gold building. With the same high standards of design being applied to the SAHMRI 2 project, it is hoped that it will achieve a Gold rating on completion. SAHMRI 2 will be purpose built to house the world-class Proton Therapy facility, whilst the upper floors will be developed to showcase the best views and vantage points Adelaide has to offer.